Tune Insight is a Switzerland-based SaaS platform that provides solutions such as data collaboration and automated collective intelligence for enterprises.
$3.4M
Sep 28, 2023
-
Genialis is a developer of cloud-based data analysis software for the visual exploration of genomics data to life scientists and biologists.
$13M
Jan 18, 2023
-
YonaLink is a Massachusetts-based clinical trial platform that offers solutions including patient data mapping and streaming for the healthcare industry.
$6M
Nov 07, 2022
-
WhiteLab Genomics is a France-based AI-powered platform that provides solutions such as genotoxicity assessment and drug discovery for the pharmaceutical sector.
$10M
Sep 12, 2022
-
Frequently Asked Questions about Debiopharm
What is Debiopharm investing in?
Debiopharm has invested in 21 companies including Raidium, Tune Insight and Genialis
What company did Debiopharm invest in?
Debiopharm invested in a total 21 companies including Raidium, Tune Insight and Genialis
What are the top 5 investments by Debiopharm?
The top companies in which Debiopharm invested are Raidium, Tune Insight, Genialis, Yonalink and WhiteLab Genomics
